title: High frequency of unrecognized indolent hematological disorders among HLA-matched siblings of patients with lymphoproliferative malignancies eligible for allo-SCT.
authors.forename: A
authors.initials: A
authors.lastname: Kolstad
authors.forename: G
authors.initials: G
authors.lastname: Tjønnfjord
authors.forename: V
authors.initials: V
authors.lastname: Jønsson
mesh_terms: D017321:Clinical Trials, Phase I as Topic; D046148:Donor Selection; D005260:Female; D019337:Hematologic Neoplasms / Q000209:etiology*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D008297:Male; D016609:Neoplasms, Second Primary / Q000209:etiology*; D014411:Neoplastic Stem Cells / Q000637:transplantation; D010375:Pedigree; D012189:Retrospective Studies; D035781:Siblings; D033581:Stem Cell Transplantation; D014019:Tissue Donors; D014184:Transplantation, Homologous